Alternative Binding Assay of GP IIb/IIIa Antagonists With a Nonradioactive Labeling Method of Platelets

By Alfon J.   Fernandez de Arriba A.   Gomez-Casajus L.A.   Merlos M.  

Thrombosis Research, Vol. 102, Iss. 3, 2001-05 ,pp. : 247-253

Elsevier

Access to resources Recommend Favorite

Fibrinogen as a Factor of Thrombosis - GP IIb/IIIa as prototypic adhesion receptor

By Zoutremepuich F.   Aguejouf O.   Belougne-Malfatti E.   Doutremepuich C.  

Thrombosis Research, Vol. 90, Iss. 2, 1998-04 ,pp. : 57-64

Elsevier

Access to resources Recommend Favorite

Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis

By Amirkhosravi Ali   Amaya Mildred   Siddiqui Farooq   Biggerstaff John P.   Meyer Todd V.   Francis John L.  

Platelets, Vol. 10, Iss. 5, 1999-10 ,pp. : 285-292

Informa Healthcare

Access to resources Recommend Favorite

Comparative Pharmacology of GP IIb/IIIa Antagonists

By Schrör Karsten   Weber Artur-Aron  

Journal of Thrombosis and Thrombolysis, Vol. 15, Iss. 2, 2003-04 ,pp. : 71-80

Springer Publishing Company

Access to resources Recommend Favorite

Effects of the glycoprotein IIb/IIIa antagonist Roxifiban on P-selectin expression, fibrinogen binding, and microaggregate formation in a phase I dose-finding study: no evidence for platelet activation during treatment with a glycoprotein IIb/IIIa antagonist

By Seiffert Dietmar   Thomas Beth E.   Bradley Jodi D.   Munzer Deborah A.   Tchinnes Maureen A.   Kornhauser David M.   Cain Valerie A.   Hua Tsuhung A.   Feuerstein Giora Z.   Martin David E.   Stern Andrew M.  

Platelets, Vol. 14, Iss. 3, 2003-05 ,pp. : 179-187

Informa Healthcare

Access to resources Recommend Favorite